Fmoc-Lys(Pal-Glu-OtBu)-OH is a protected amino acid derivative used as a pharmaceutical intermediate. Its structure features a palmitoyl chain, a glutamate residue with a tert-butyl ester protecting group, and an Fmoc-protected lysine backbone, making it suitable for solid-phase peptide synthesis.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1491158-62-3
Fmoc-Lys[|A-Glu(OtBu)-C18-OtBu)]-OH
solid phase peptide synthesis reagent
Fmoc-L-Lys[C20-OtBu-L-Glu(OtBu)-AA-AA]-OH
Pharmaceutical intermediate for peptide synthesis
(3R,4S)-tert-Butyl 2-oxo-4-phenyl-3-(triethylsilyloxy)azetidine-1-carboxylate
Pharmaceutical intermediate for beta-lactam synthesis
(3R,4S)-1-BENZOYL-4-PHENYL-3-[(TRIETHYLSILYL)OXY]-2-AZETIDINONE
Key intermediate for Taxol synthesis
1-Fluoro-2-nitrobenzene
Pharmaceutical intermediate
Tert-butyl N-[(pyrrolidin-3-yl)methyl]carbamate
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[[(4S)-4-(hexadecanoylamino)-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoyl]amino]hexanoic acid
LQQXBYSAGYOQJW-ZAQUEYBZSA-N
CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)C(=O)OC(C)(C)C